Профиль компании
- Фондовый код
- IBRX
- ISIN-код
- US45256X1037
- Валюта
- US Dollar (USD)
- Дата IPO
- 2015-07-28

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion pr...